A Pune-based Indian firm, Serum Institute of India, has planned to start the production of coronavirus vaccine by the next few weeks. It will produce the vaccine developed by Oxford University.
Oxford University and Serum Institute are partners in coronavirus vaccine production. The CEO of Serum Insitute said that, if the human trials are successful then the vaccine will be available by September or October.
However, the human trials of the vaccine will begin in May where only a few hundred patients will be put on trial. Also, the price for the dose is proposed by the firm saying we want to make it affordable for the patients. But the price does not seem affordable as it will be around Rs 1,000 per dose.
Moreover, the CEO said that we cannot wait for the production of vaccine after the human trial ends in the UK. As human trials in the UK will end by September. So, we are producing the vaccine at our own risk after the clinical trials.
The SII is planning to make around 20-40 mn doses of vaccine by October. SII CEO further said we are spending around $150 million in the production including both direct and indirect costs.
Furthermore, he added that we hope that the government will help us so as to recover the cost of production.
Almost five vaccines of coronavirus have already entered into the clinical trials phase and this will be the sixth one. If the trials are successful then we can expect the production of vaccines in the lump sum amount.